Clinical, Genetic and Functional Characterization of a Novel AVPR2 Missense Mutation in a Woman with X-Linked Recessive Nephrogenic Diabetes Insipidus

被引:2
作者
Selvaraj, Senthil [1 ]
Rodrigues, Dircea [2 ]
Krishnamoorthy, Navaneethakrishnan [1 ]
Fakhro, Khalid A. [1 ,3 ,4 ]
Saraiva, Luis R. [1 ,4 ,5 ]
Lemos, Manuel C. [6 ]
机构
[1] Sidra Med, Dept Genet, POB 26999, Doha, Qatar
[2] Ctr Hosp Univ Coimbra, Serv Endocrinol Diabet & Metab, P-3000075 Coimbra, Portugal
[3] Weill Cornell Med Coll, Dept Med Genet, POB 24144, Doha, Qatar
[4] Hamad Bin Khalifa Univ, Coll Hlth & Life Sci, POB 24144, Doha, Qatar
[5] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA
[6] Univ Beira Interior, Hlth Sci Res Ctr, CICS UBI, P-6200506 Covilha, Portugal
来源
JOURNAL OF PERSONALIZED MEDICINE | 2022年 / 12卷 / 01期
关键词
vasopressin; AVPR2; nephrogenic diabetes insipidus; genetics; case report; V2 VASOPRESSIN RECEPTOR; OREXIN; PATHOPHYSIOLOGY; IDENTIFICATION; EXPRESSION; CELLS; DEGRADATION; ANTAGONISTS; PHYSIOLOGY; VARIANTS;
D O I
10.3390/jpm12010118
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Nephrogenic diabetes insipidus (NDI) is a rare disorder characterized by renal unresponsiveness to the hormone vasopressin, leading to excretion of large volumes of diluted urine. Mutations in the arginine vasopressin receptor-2 (AVPR2) gene cause congenital NDI and have an X-linked recessive inheritance. The disorder affects almost exclusively male family members, but female carriers occasionally present partial phenotypes due to skewed inactivation of the X-chromosome. Here, we report a rare case of a woman affected with X-linked recessive NDI, presenting an average urinary output of 12 L/day. Clinical and biochemical studies showed incomplete responses to water deprivation and vasopressin stimulation tests. Genetic analyses revealed a novel heterozygous missense mutation (c.493G > C, p.Ala165Pro) in the AVPR2 gene. Using a combination of in-silico protein modeling with human cellular models and molecular phenotyping, we provide functional evidence for phenotypic effects. The mutation destabilizes the helical structure of the AVPR2 transmembrane domains and disrupts its plasma membrane localization and downstream intracellular signaling pathways upon activation with its agonist vasopressin. These defects lead to deficient aquaporin 2 (AQP2) membrane translocation, explaining the inability to concentrate urine in this patient.
引用
收藏
页数:14
相关论文
共 52 条
  • [1] GENETICS IN ENDOCRINOLOGY Pathophysiology, diagnosis and treatment of familial nephrogenic diabetes insipidus
    Bichet, Daniel G.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2020, 183 (02) : R29 - R40
  • [2] HEMODYNAMIC AND COAGULATION RESPONSES TO 1-DESAMINO[8-D-ARGININE] VASOPRESSIN IN PATIENTS WITH CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS
    BICHET, DG
    RAZI, M
    LONERGAN, M
    ARTHUS, MF
    PAPUKNA, V
    KORTAS, C
    BARJON, JN
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (14) : 881 - 887
  • [3] MOLECULAR-CLONING OF THE RECEPTOR FOR HUMAN ANTIDIURETIC-HORMONE
    BIRNBAUMER, M
    SEIBOLD, A
    GILBERT, S
    ISHIDO, M
    BARBERIS, C
    ANTARAMIAN, A
    BRABET, P
    ROSENTHAL, W
    [J]. NATURE, 1992, 357 (6376) : 333 - 335
  • [4] Functional characterization of novel loss-of-function mutations in the vasopressin type 2 receptor gene causing nephrogenic diabetes insipidus
    Boeselt, Iris
    Tramma, Despoina
    Kalamitsou, Serafia
    Niemeyer, Thomas
    Nykanen, Paivi
    Graef, Klaus-Juergen
    Krude, Heiko
    Marenzi, Karen Sabrina
    Di Candia, Stefania
    Schoeneberg, Torsten
    Schulz, Angela
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (04) : 1521 - 1528
  • [5] Physiology and pathophysiology of the vasopressin-regulated renal water reabsorption
    Boone, Michelle
    Deen, Peter M. T.
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2008, 456 (06): : 1005 - 1024
  • [6] Stimulation of AQP2 membrane insertion in renal epithelial cells in vitro and in vivo by the cGMP phosphodiesterase inhibitor sildenafil citrate (Viagra)
    Bouley, R
    Soler, NP
    Cohen, O
    McLaughlin, M
    Breton, S
    Brown, D
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2005, 288 (06) : F1103 - F1112
  • [7] Identification and Characterization of an Activating F229V Substitution in the V2 Vasopressin Receptor in an Infant with NSIAD
    Carpentier, Eric
    Greenbaum, Larry A.
    Rochdi, Driss
    Abrol, Ravinder
    Goddard, William A., III
    Bichet, Daniel G.
    Bouvier, Michel
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (10): : 1635 - 1640
  • [8] Christ-Crain M, 2019, NAT REV DIS PRIMERS, V5, DOI [10.1038/s41572-019-0114-z, 10.1038/s41572-019-0103-2]
  • [9] Acute effects of vasopressin V2-receptor antagonist on kidney AQP2 expression and subcellular distribution
    Christensen, BM
    Marples, D
    Jensen, UB
    Frokiaer, J
    Sheikh-Hamad, D
    Knepper, M
    Nielsen, S
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1998, 275 (02) : F285 - F297
  • [10] Proline-induced distortions of transmembrane helices
    Cordes, FS
    Bright, JN
    Sansom, MSP
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2002, 323 (05) : 951 - 960